MSB 12.1% 55.5¢ mesoblast limited

No :(. From the clinical trial info site about the Phase 3...

  1. 3,702 Posts.
    lightbulb Created with Sketch. 1263
    No .
    From the clinical trial info site about the Phase 3 Crohn's Disease trial;
    https://clinicaltrials.gov/ct2/show/NCT00482092

    Column 1 Column 2
    0 Estimated Primary Completion Date : July 2018
    1 Estimated Study Completion Date : July 2020

    Some time during July 2018 it is thought the final Primary measure will be taken from the last person enrolled in the trial which is, are they in remission i.e. are they cured of Crohn's Disease at least for the time being as per the Primary outcome measure. We should be told the outcome of the Primary and Secondary measures in a month or two after July 2018.

    The Phase 3 trial does not finish until around July 2020, my guess is to see how long the treatment lasts for. Do the effects last for at least 2 years, or less, will any re-treatment be necessary.

    So we wait, unless the FDA changes the rules about how much needs to be known over the following years before release could be considered.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
4 62700 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 40000 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 29/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.